IL4 and cyst: To conclude, we showed that the in-vitro IL-4-specific-response measurement in whole-blood, although associated with cyst viability, is probably not informative enough of the viability and reactivation of the cyst to be used in clinical practice, although a clear valuation of assay performance for patients’ follow-up could not be performed.